Monitoring Health Outcomes Following Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis
- 6 January 2007
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 14 (3), 1105-1113
- https://doi.org/10.1245/s10434-006-9304-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future DirectionsAnnals of Surgical Oncology, 2005
- Impact of tumor resection (Rxn) and intraperitoneal (IP) chemotherapy (CHRx) on health related quality of life (HRQL) in patients (Pts) with peritoneal surface malignancies (PSM)Annals of Surgical Oncology, 2004
- Screening for depression in head and neck cancerPsycho‐Oncology, 2003
- Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.Annals of Surgical Oncology, 2003
- Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosisEuropean Journal of Surgical Oncology, 2001
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.Journal of Clinical Oncology, 1993
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- Peritoneal carcinomatosis: Anatomy, physiology, diagnosis, managementCurrent Problems in Cancer, 1986
- The CES-D ScaleApplied Psychological Measurement, 1977